Fatty liver disease

When a new year rolls around, many of us naturally turn our attention to health. I’ve made enough resolutions over the years to know that…

Madrigal Pharmaceuticals, the maker of Rezdiffra (resmetiron), has acquired three new experimental treatments for metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty…

Humans tend to love animals — especially the fuzzy, cuddly kind. I’m no exception. Anyone who knows me knows my devotion to my three cats:…

About one year of treatment with Altimmune’s experimental therapy pemvidutide led to reductions in noninvasive markers of liver scarring (fibrosis) in people with metabolic…

Throughout 2025, the team at Liver Disease News has reported on the latest research and advances in care related to various rare and non-rare liver…

Health Canada has conditionally approved Novo Nordisk’s Wegovy (semaglutide) to treat metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease. The…

The U.S. Food and Drug Administration (FDA) has authorized the use of the first artificial intelligence (AI) drug-development tool for use in clinical trials of metabolic…

The past two months have been a whirlwind. I had my left knee replaced in late October, which forced me to slow down and truly…

TAEUS, a diagnostic tool being developed by Endra Life Sciences, measures liver fat levels with similar accuracy to gold-standard tests, but with greater convenience…

A few years ago, I had a frightening visit with my doctor. I’d just moved into my new house and changed my cellphone number, and…